Ascendis Health (JSE:ASC) Gross-Profit-to-Asset % : 49.45% (As of Jun. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Ascendis Health Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Ascendis Health's annualized Gross Profit for the quarter that ended in Jun. 2023 was R585 Mil. Ascendis Health's average Total Assets over the quarter that ended in Jun. 2023 was R1,183 Mil. Therefore, Ascendis Health's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2023 was 49.45%.

Ascendis Health Gross-Profit-to-Asset % Historical Data

The historical data trend for Ascendis Health's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascendis Health Gross-Profit-to-Asset % Chart

Ascendis Health Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

19.16

7.19

6.06

10.36

45.65

Ascendis Health Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															9.94	11.02	34.69	40.59	49.45

Competitive Comparison of Ascendis Health's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Ascendis Health's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ascendis Health's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ascendis Health's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Ascendis Health's Gross-Profit-to-Asset % falls into.

Ascendis Health Gross-Profit-to-Asset % Calculation

Ascendis Health's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Jun. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Jun. 2023 )	/	( (Total Assets (A: Jun. 2022 )	+	Total Assets (A: Jun. 2023 ))	/ count )
	=	604.531	/	( (1677.598	+	970.711)	/ 2 )
	=	604.531	/	1324.1545
	=	45.65 %

Ascendis Health's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Jun. 2023 )	/	( (Total Assets (Q: Dec. 2022 )	+	Total Assets (Q: Jun. 2023 ))	/ count )
	=	585.272	/	( (1396.254	+	970.711)	/ 2 )
	=	585.272	/	1183.4825
	=	49.45 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Jun. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Ascendis Health Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Ascendis Health's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Ascendis Health (JSE:ASC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ascendis Health Ltd (JSE:ASC) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Carey Street, Wynberg, Sandton, GT, ZAF, 2090

Website

https://www.ascendishealth.com

Ascendis Health is a drug manufacturer that produces and distributes health products for the human, animal, and plant markets. It has a portfolio of brands and products and owns recognized trademarks in the pharmaceutical and consumer health markets. Ascendis Health has five operating segments: consumer health, pharma, medical, animal health, and biosciences. The pharma division is the contributor to revenue and is further divided into Pharma Africa, Remedica, and Farmalider. Pharma includes generic manufacturing and distribution and over-the-counter medicine manufacturing and distribution. The company's revenue is split between South Africa and Europe and is diversified across currencies, markets, sales channels, and customer groups.